ARCHIVES

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

SEER Program Expansion Through Cost-Sharing.

March 23, 2001

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997

Scientists, Industry Identify Barriers To Development of Molecular Therapies

April 12, 2002

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

DCE Publishes Lister of Resources Available To Scientific Community

November 9, 1984

Obituary: Connie Curran, 67, C-Change Executive Director

November 21, 2014